United States will pay vaccine maker Novavax $1.6 billion to develop 100 million doses of a coronavirus vaccine by early 2021
The Trump Administration’s Operation Warp Speed has struck a $1.6 billion deal with Maryland-based company Novavax {NASDAQ:NVAX} to fast trackContinue Reading